Boris Bahoric, MD
Jewish General Hospital
Dr. Bahoric completed his medical school in Rijeka, Croatia. He completed his Royal College Fellowship Program in Radiation oncology in Toronto. He works as staff radiation oncologist at the Jewish General Hospital in Montreal. He is assistant professor at McGill University. Apart from teaching he is involved in various administrative activities. His areas of interest and expertise are the gynecological, genitourinary and hematological malignancies. Particularly, he is interested in brachytherapy. He offers both intracavitary and interstitial for gynecological malignancies. He performs adjuvant accelerated partial breast irradiation via interstitial brachytherapy. Dr. Bahoric participates in nationwide studies in prostate cancer. As part of the studies he offers and performs HDR prostate brachytherapy. He is past president of Canadian Brachytherapy Group and is still active participant in this group.
Marie Claude Beauchemin, MD
CHUM
Isabelle Germain, MD
Hôtel Dieu de Québes
Melanie Gionet, MD
Rimouski
Marjory Jolicoeur, MD
Université de Montréal - Hôpital Charles Lemoyne
With an MD degree from the Université de Montréal, Dr. Marjory Jolicoeur founded Curietherapies in 2012, a non-profit organization that she still presides over today. A renowned radiation oncologist, she did her residency at Université de Montreal in 1996, before completing a brachytherapy fellowship at the Centre Georges-François Leclerc located in Dijon (France). In 1997, she started working at the department of Radiation Oncology of Université de Montréal, where she still teaches. A mere two years later, she was appointed medical consultant for all planning, construction and equipment selection processes of the new Radiation Oncology department of Hospital Charles-Le Moyne. She innovates by equipping the department with a suite and a comprehensive image-guided brachytherapy program. As a brachytherapy specialist, she has special research interests in its application to pathologies such as breast, genitourinary and gynecologic cancers. Her main focus is on the development of image guided implant procedures, the use of MRI in brachytherapy and the precision delivery of conformal high dose rate brachytherapy. She also teaches brachytherapy nationally and internationally.
Maryse Mondat, Physicienne médical
HCLM
A obtenu son M.SC. de l’université McGill en physique du solide en 1982. Après plusieurs années d’enseignement, elle s’est spécialisée en physique médicale appliquée à la radio-oncologie. Elle travaille dans cette spécialité depuis 1989. Elle a fait sa certification MCCPM et FCCPM en 2000 (membre et fellow du Collège canadien des physiciens en médecine). Elle a travaillé 2 ans à l’hôpital de Chicoutimi, 9 ans au Centre hospitalier de l’université de Montréal et 10 ans à l’hôpital Maisonneuve-Rosemont. Durant ces années, elle a eu la chance de toucher les différents secteurs de la physique médicale en radio-oncologie : acceptation des appareils de traitement en téléthérapie, modélisation des plans de traitement, dosimétrie de techniques spéciales, radioprotection et curiethérapie. Depuis 2010, elle est responsable de la physique médicale section curiethérapie à l’hôpital Charles LeMoyne.
Thu Van Nguyen, MD
Thu Van Nguyen Huynh est radio-oncologue et travaille à Hôpital Charles Lemoyne depuis 2013. Après son fellow en gynécologie-curiethérapie HDR à Madison au Wisconsin, elle a passé 15 ans au sein de l’équipe du à collaborer avec le groupe de gynécologie-oncologie et d’urologie-oncologique, en plus de contribuer à la formation des résidents du programme de radio-oncologie de l’Université de Montréal. Ses intérêts demeurent les cancers gynécologiques/urologiques, la curiethérapie gynécologique et le bien-être du patient. Thu Van Nguyen Huynh is radiation oncologist working at Charles Lemoyne Hospital since 2013. In 1997-98, she did a fellow in gynecology/HDR brachytherapy in Madison, Wisconsin then was attending physician for 15 years at the Centre Hospitalier de l’Université de Montréal (CHUM). She contributed to the radiation oncology program and to teach a generation of residents at the University of Montreal program. Her main interests are urologic/gynecologic cancers, gynecologic brachytherapy and the aim of patient welfare.
Marie Lynn Racine, MD
Université de Sherbrooke - Hôpital Charles Lemoyne
Dre. Marie-Lynn Racine has completed her residency in Radiation Oncology at the Université de Montréal. She has completed a first Fellowship in Brachytherapy at the Brigham and Women’s Hospital affiliated with the Harvard Medical School in Boston and a second Fellowship at the Centre Alexis-Vautrin in Nancy. She is currently working at the Hôpital Charles Lemoyne on the south shore of Montréal.